THE APEX TIMES
Speaking at the WSJ Leadership Institute’s CMO Council Summit, PepsiCo’s Mark Kirkham described the company’s efforts to understand how GLP-1 medications are reshaping consumption patterns, and how that could influence its beverage strategy.
PepsiCo is looking at consumers using GLP-1 weight-loss and diabetes medicines as a growing, distinct audience, and it is trying to adapt its beverage marketing to their needs, an executive said in a recent interview.
The remarks came from Mark Kirkham, a PepsiCo leader involved in the company’s beverage business, who spoke with Megan Graham of the WSJ Leadership Institute at the WSJLI CMO Council Summit in New York. In the interview, which was posted by Yahoo Finance, Kirkham framed GLP-1 users as a “new market” for PepsiCo’s beverage portfolio.
While the interview does not provide granular details in the post itself, the central message is that GLP-1 adoption is changing how some consumers think about food and drinks, including considerations like portion sizes, taste preferences, and what people choose to drink as part of weight-management routines.
PepsiCo’s approach, as characterized in the interview, emphasizes understanding that segment’s motivations and constraints, then aligning product and messaging accordingly. Kirkham’s focus on the “new market” suggests the company sees GLP-1 usage as more than a passing trend for beverage consumption, but rather as an emerging behavioral shift that marketing teams need to plan for.
The company’s broader positioning in beverages also matters in this context. PepsiCo operates at the center of packaged beverages categories where brand perception and taste cues are major drivers of repeat purchase, and where shifts in consumer behavior can quickly affect demand. In that setting, a segment that may be more health-focused or more deliberate in selecting drinks can become a strategic priority.
Industry-wide, GLP-1 medications have accelerated attention on diet and nutrition, with many consumers reporting changes in appetite and cravings after starting treatment. However, the video post itself does not spell out which specific products, flavors, or campaigns PepsiCo is prioritizing for GLP-1 users, nor does it disclose any measurable targets tied to that audience.
The most important gap for readers is what PepsiCo did not disclose in the interview posting: there are no figures, no named initiatives, and no timeline. The post also does not indicate whether PepsiCo is making changes to formulations, expanding a dedicated GLP-1-focused lineup, or relying on existing brands with adjusted marketing.
Still, the discussion indicates that PepsiCo’s marketing leadership is treating GLP-1 adoption as a consumption trend with implications for how beverages are presented and packaged in consumers’ minds. The next question is whether PepsiCo will connect that strategy to specific execution, such as campaign launches, retailer plans, or product-level decisions as the GLP-1 market grows.
TD Cowen placed Coca-Cola on a forward-looking “best idea” list for 2027, pointing to the company’s longer-term growth outlook and underlying business strength, according to a report syndicated by Yahoo Finance.
In a WSJ Leadership Institute discussion, PepsiCo Beverages U.S. marketing leadership described a strategy that pairs fan communities with data-driven campaign targeting, while using artificial intelligence to expand how marketing content travels across platforms.
A new wave of holiday menu tie-ins, a planned nationwide value menu and wider tests of AI-assisted ordering are among the initiatives investors are watching at McDonald’s.
A new investor-focused writeup points to Home Depot’s push to sell roughly 2,000 exclusive items as a way to make the retailer the default destination for homeowners and contractors.
The firm raised its price target for Costco (COST) to $1,257 from $1,095 and reiterated a Buy rating, pointing to roughly 13% upside from its referenced level.
Target is scheduled to report third-quarter earnings on Nov. 18. Ahead of the release, Barchart’s options-based read suggests traders expect the stock to move lower once results land.
The warehouse club is drawing attention to a seasonal item that shoppers may not expect to see on shelves, according to a report cited by Yahoo Finance.
A new market note highlights how the lack of a clear revenue turnaround has weighed on sentiment, with investors also focusing on how quickly disappointment is being priced into Nike’s value.
Traders weighed a potential sales slowdown against the apparel maker’s longer-term targets, sending Nike’s stock lower on Nov. 17, 2026.
In comments reported ahead of or around Nike’s investor messaging, the company suggested a timeline for stabilizing performance across its Jordan and Converse brands.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...